Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Segawa's disease].

H Ichinose1

  • 1Institute for Comprehensive Medical Science, Fujita Health University.

Rinsho Shinkeigaku = Clinical Neurology
|July 24, 2001
PubMed
Summary
This summary is machine-generated.

Measuring GTP cyclohydrolase I activity in blood cells offers a valuable diagnostic method for Segawa's disease (dopa-responsive dystonia), even when genetic mutations are not found.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of tyrosine hydroxylase mRNA.

Methods in molecular medicine·2011
Same author

Cascade-connective optical parallel logic processor using electrophotonic devices.

Applied optics·2010
Same author

H(2)O(2) increases de novo synthesis of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin via GTP cyclohydrolase I and its feedback regulatory protein in vitiligo.

Journal of inherited metabolic disease·2008
Same author

A statistical mechanical theory for the adsorption of protein to liposomal membranes.

Biophysical chemistry·2006
Same author

Peptide synthesis catalyzed by organic solvent-stable protease from Pseudomonas aeruginosa PST-01 in monophasic aqueous-organic solvent systems.

Journal of bioscience and bioengineering·2005
Same author

p16INK4a IHC in the diagnosis of cervical CIN.

The American journal of surgical pathology·2003
Same journal

[Let's present at a regional meeting].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Editor's Note].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Notice for Members].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[The Proceedings of the 250th Kyushu Regional Meeting of the Japanese Society of Neurology].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[The Proceedings of the 116th Tohoku Regional Meeting of the Japanese Society of Neurology].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Metagenomic analysis for central nervous system infections: clinical utility and future directions].

Rinsho shinkeigaku = Clinical neurology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Context:

  • Segawa's disease, or dopa-responsive dystonia, is linked to mutations in the GTP cyclohydrolase I gene.
  • Tetrahydrobiopterin biosynthesis is crucial and regulated by GTP cyclohydrolase I.
  • Genetic identification of mutations is not always conclusive in Segawa's disease patients.

Purpose:

  • To assess the diagnostic utility of measuring GTP cyclohydrolase I enzyme activity in phytohemagglutinin-stimulated mononuclear blood cells.
  • To explore a biochemical assay as a complementary diagnostic tool for Segawa's disease.
  • To evaluate the potential of enzyme activity measurement to distinguish patients from healthy individuals.

Summary:

  • GTP cyclohydrolase I activity was measured in stimulated mononuclear blood cells from Segawa's disease patients.

Related Experiment Videos

  • This method assesses the maximum induction capacity of the enzyme, potentially revealing differences masked by compensatory mechanisms.
  • The assay can differentiate patients from normal individuals, particularly when genetic mutations are not identifiable in coding regions or exon-intron junctions.

    • Impact:

    • Provides a valuable biochemical assay for diagnosing Segawa's disease, especially in cases with unidentified genetic mutations.
    • Offers a method to evaluate enzyme induction capacity, aiding in understanding disease pathophysiology.
    • Enhances diagnostic capabilities beyond genetic testing for dopa-responsive dystonia.